Publication: American Journal of Managed Care
Debra Patt, M.D., Ph.D., MBA, Executive Vice President, Public Policy, Payer Relations, and Strategic Initiatives at Texas Oncology, conducted interview after interview during the ASCO annual meeting to explain the significance of the meeting's largest trial, DESTINY-Breast04. The trial will be a game changer for patients with advanced HER2-low breast cancer.
Click here to read the full article.